ClinicalTrialsFinder

Bone Metastases Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study

Triple-Negative Breast CancerBone Metastases
Zhejiang Cancer Hospital20 enrolled1 locationNCT06538896